<DOC>
	<DOCNO>NCT00221364</DOCNO>
	<brief_summary>The WHO initiate program eliminate blinding trachoma year 2020 , large part mass oral azithromycin distribution . It clear frequently long treatment necessary . Here assess frequency duration treatment .</brief_summary>
	<brief_title>Trachoma Elimination Follow-up</brief_title>
	<detailed_description>40 village Gurage Zone Ethiopia randomly assign biannual treatment , annual treatment , single treatment . Each treatment consist single dose oral azithromycin entire population age 1 year ( study start , azithromycin yet approve age 1 year ) . We assess prevalence ocular chlamydia cause trachoma peak prevalence age 1-5 year baseline , 2 , 6 , 12 , 18 , 24 month post treatment . An extension study monitor infection 30 36 month post treatment . Untreated village area enrol step-wedge design ass presence secular trend . A random sample within 1-5 year old age group examine assess prevalence infection entire community .</detailed_description>
	<mesh_term>Chlamydia Infections</mesh_term>
	<mesh_term>Trachoma</mesh_term>
	<criteria>Age 1 5 year old village Gurage zone endemic trachoma Refusal village chief ( village inclusion ) , refusal parent guardian ( individual inclusion )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Trachoma</keyword>
	<keyword>Chlamydia</keyword>
	<keyword>Azithromycin</keyword>
</DOC>